Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Biochemical Reagents >  Agonist Inhibitors >  SAR131675

SAR131675

Basic information Safety Supplier Related

SAR131675 Basic information

Product Name:
SAR131675
Synonyms:
  • SAR131675
  • SAR131675/SAR-131675
  • (-)-2-Amino-1-ethyl-1,4-dihydro-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-N-methyl-4-oxo-1,8-naphthyridine-3-carboxamide
  • (R)-2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1
  • SAR131675 Racemate
  • 1,8-Naphthyridine-3-carboxamide, 2-amino-1-ethyl-1,4-dihydro-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-N-methyl-4-oxo-, (-)-
  • 2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-n-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide
  • (Rac)-SAR131675
CAS:
1092539-44-0
MF:
C18H22N4O4
MW:
358.39
Mol File:
1092539-44-0.mol
More
Less

SAR131675 Chemical Properties

Melting point:
>206°C (dec.)
Boiling point:
592.2±50.0 °C(Predicted)
Density 
1.33±0.1 g/cm3(Predicted)
storage temp. 
Refrigerator
solubility 
Chloroform (Slightly), DMSO (Slightly)
pka
12.20±0.29(Predicted)
form 
Solid
color 
White to Pale Yellow
More
Less

SAR131675 Usage And Synthesis

Uses

SAR131675 is a VEGFR-3 inhibitor with IC50 of 20 nM.

Synthesis

42841-64-5

1092523-24-4

1092538-80-1

3 g (10.69 mmol) of 2-amino-7-chloro-1-ethyl-N-methyl-4-oxo-1,4-dihydro[1,8]diazanaphthalene-3-carboxamide was suspended in 20 mL of methanol in an 80 mL microwave tube. A DMF/Et3N mixture (V/V; 1/1) was added to the suspension followed by argon bubbling for 10 min. 1.83 g (±)-1-methoxy-2-methyl-3-butyn-2-ol (16.03 mmol), 0.081 g CuI (0.43 mmol), and 0.375 g bis(triphenylphosphine)palladium(II) dichloride (0.53 mmol) were added sequentially. The sealed tube was placed in a microwave reactor (CEM Discover model) and heated at 90 °C for 60 min at 100 W power. After completion of the reaction, the mixture was cooled and evaporated to dryness. The residue was dissolved in mixed ethyl acetate/THF solvent and washed with 0.1 N HCl aqueous solution. The organic phase was dried over anhydrous sodium sulfate, filtered and concentrated in vacuum. The residue was purified by silica gel column chromatography (dry sample, elution gradient: cyclohexane/ethyl acetate, 30:70 to 20:80) to give 2.49 g of light yellow solid product. The product can be recrystallized from ethanol to give white crystals with a melting point of 211 °C. Mass spectrum (MH+): 358. yield: 65%.1H NMR (DMSO-d6, 400 MHz, δ ppm): δ 11.75 (s, <1H, broad peak); 11.00 (q, 1H, broad peak); 8.45 (d, 1H); 8.00 (s, 1H, broad peak); 7.4 (d, 1H); 5.8 (s, 1H); 4.4 (q, 2H); 3.5 (q, 2H). 2H); 3.5-3.3 (m + s, 5H); 2.8 (d, 3H); 1.45 (s, 3H); 1.2 (t, 3H).

IC 50

VEGFR3

References

[1] Patent: US2010/144757, 2010, A1. Location in patent: Page/Page column 8

SAR131675Supplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Jinan Trio PharmaTech Co., Ltd.
Tel
0531-88811783
Email
sales@trio-pharmatech.com
SYN|thesis med chem P/L
Tel
+86-021-50720296
Email
service@synkinase.com
Credit Asia Chemical Co., Ltd.
Tel
+86 (21) 61124340
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Email
sales@letopharm.com